Cell Source Inc. Intrinsic Value

CLCS

Cell Source fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Cell Source today, so there is nothing to project yet.

SourceFair value computed from the 10-Q filed 13 May 2026, covering the period ending 31 Mar 2025, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Price from market data, last close as of 4 Nov 2026. Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CLCS

CompareIntrinsic value

CBIOCrescent Biopharma, Inc.

$12.94-6.37%50

AYTUAytu BioPharma Inc.

$1.81-5.73%48

JNJJohnson & Johnson

$272.32-1.45%53

ORGSOrgenesis Inc.

$0.49+949.25%20

LGVNLongeveron Inc.

$1.71-3.93%10

ALXOAlx Oncology Holdings Inc.

$1.15-15.44%10

BPTHBio-Path Holdings Inc.

$0.00-40.00%20

CYDYCytoDyn Inc.

$0.23-1.83%0

Spot a number that looks wrong? Check it in CLCS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CLCS

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.